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ABSTRACT
In Caenorhabditis elegans, as in other animals, Notch-type signaling mediates numerous inductive events
during development. The mechanism of Notch-type signaling involves proteolytic cleavage of the receptor
and subsequent transport of the receptor intracellular domain to the nucleus, where it acts as a
transcriptional regulator. Notch-type signaling activity is modulated by post-translational modifications
and endocytosis of ligand and receptor. We previously identified the ego-2 (enhancer of glp-1) gene as a
positive regulator of germline proliferation that interacts genetically with the GLP-1/Notch signaling
pathway in the germline. Here, we show that ego-2 positively regulates signaling in various tissues via both
GLP-1 and the second C. elegans Notch-type receptor, LIN-12. ego-2 activity also promotes aspects of
development not known to require GLP-1 or LIN-12. The EGO-2 protein contains a Bro1 domain, which
is known in other systems to localize to certain endosomal compartments. EGO-2 activity in the soma
promotes GLP-1 signaling in the germline, consistent with a role for EGO-2 in production of active ligand.
Another C. elegans Bro1-domain protein, ALX-1, is known to interact physically with LIN-12/Notch. We
document a complex phenotypic interaction between ego-2 and alx-1, consistent with their relationship
being antagonistic with respect to some developmental processes and agonistic with respect to others.

C

ELL–CELL signaling is essential for the regulation
of developmental decisions in multicellular organisms. Notch-type signaling has been implicated
in developmental decisions in diverse animal species
and often regulates the proliferation vs. differentiation
decision (Weinmaster and Kopan 2006; Wilson and
Radtke 2006). In Caenorhabditis elegans, Notch-type signaling mediates numerous inductive events during embryonic and larval development and in the adult gonad
(Greenwald 2005). C. elegans has two Notch-type receptors, GLP-1 and LIN-12; they are partially redundant for
function in the embryo, but have separate roles in older
animals. GLP-1 functions in numerous inductive events
in the early embryo (Priess 2005), and GLP-1 signaling
in the larva and adult maintains proliferation of the
developing germline (Kimble and Crittenden 2005).
LIN-12 functions in several cell–cell interactions in the
embryo (redundantly with GLP-1) and larvae; its role
has been most closely studied in the developing vulva,
where it is required for several distinct inductive events
(Greenwald 2005).
The canonical Notch pathway has been elucidated by
studies in Drosophila and mammals, as well as in C.
elegans. A transmembrane Delta/Serrate/LAG-2 (DSL)
family ligand produced by the signaling cell(s) binds the
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transmembrane Notch-type receptor in the receiving
cell(s) (see Ehebauer et al. 2006). Upon ligand-receptor
binding, two cleavage events, called S2 and S3, release
the extracellular and intracellular domains of the receptor, respectively. The intracellular domain is transported to the nucleus where it interacts with CBF1/
Su(H)/LAG-1 (CSL) family transcriptional regulators
and other proteins to form a transcriptional activation
complex. Signaling pathway activity is modulated in
numerous ways, including by post-translational modifications and endocytosis of pathway components in both
the signaling and the receiving cell (Schweisguth
2004).
Germline proliferation in C. elegans depends on inductive signals from the somatic gonad that are mediated
by GLP-1/Notch. The germline begins to proliferate
in early larval development in response to signals from
the somatic gonad (Greenwald 2005; Kimble and
Crittenden 2005). In mid-larval development, proximal germ cells enter meiosis, and proliferation is maintained only in the distal germline. At this time, the
somatic distal tip cell (DTC) becomes the sole source of
signal; the major DSL-type ligand produced by the DTC
is LAG-2. Upon ligand binding, the GLP-1 intracellular
domain is thought to be released and transported to the
nucleus where it interacts with the CSL-type transcription factor, LAG-1, and an adaptor protein, SEL-8/LAG-3,
to activate transcription of target genes (Greenwald
2005; Kimble and Crittenden 2005). When signaling
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is compromised by ablation of somatic signaling cells
or mutation in a GLP-1/Notch pathway component,
germ cells prematurely exit mitosis, enter meiosis, and
differentiate (Kimble and Crittenden 2005; Hansen
and Schedl 2006).
To identify factors that regulate Notch-type signaling
in the gonad, our laboratory previously recovered ego
(enhancer of glp-1) mutations that enhanced the germline phenotype of a weak glp-1 loss-of-function mutation
(Qiao et al. 1995; J. Spoerke, P. Shu and E. Maine,
unpublished data). A single ego-2 mutation, om33, was
isolated in that study. Here, we report a molecular and
genetic analysis of ego-2. We show that ego-2 encodes a
Bro1-domain protein whose activity promotes GLP-1/
Notch signaling in the gonad and embryo, and LIN-12/
Notch signaling in the AC–ventral uterine (VU) decision. We find that ego-2 activity in the soma promotes
GLP-1 signaling in the germline, suggesting that EGO-2
may promote the production of active ligand. We also
show that ego-2 activity promotes spermatogenesis and
several aspects of somatic development not known to
require Notch-type signaling. The C. elegans genome
contains a second Bro1-domain-encoding gene, alx-1
(Alix-like). We describe a complex genetic relationship
between ego-2 and alx-1, which suggests that the EGO-2
and ALX-1 proteins may promote some common aspects of development and act in opposition to regulate
others. Bro1-domain proteins in a variety of organisms
have been shown to localize to endosomal compartments
(Odorizzi 2006). We hypothesize that EGO-2 may participate in endosomal-based processes that modulate
Notch-type signaling.
MATERIALS AND METHODS
Nematode strains and culture: Standard culture conditions
were used (Epstein and Shakes 1995). Wild-type strains C.
elegans variant Bristol (N2) and CB4856 (‘‘HA8’’) and mutations used are as described by Chen et al. (2003), as listed in
Wormbase (http://www.wormbase.org), or as described in the
text. Mutations used were the following: linkage group (LG)
I—ego-2(om33), ego-2(tm2272), fog-1(q253ts), gld-1(q485), gld2(q497), rrf-1(pk1417), unc-75(e950), hIn1[unc-54(h1040)], hDf17,
ccIs4251; LGII—rrf-3(pk1426); LGIII—alx-1(gk412), dpy-17(e164),
glp-1(ar202), glp-1(bn18ts), glp-1(e2142ts), glp-1(oz112gf), lin11(n389), lin-12(ar170), lin-12(n302gf), unc-32(e189), unc36(e251), hT2[bli-4(e937) let-?(q782) qIs48] (I;III). A cdh-3Tgfp
transgene was used as a marker for the anchor cell (AC) (Inoue
et al. 2002). ACs were identified by comparing the differential
interference contrast and CDH-3TGFP fluorescence images at
high magnification (3400, 3630). The phenotype was scored
early in vulva formation, prior to the time when CDH-3 expression becomes visible in the vulval precursor cell descendants
(see Inoue et al. 2002). To test for suppression of a weak lin12(gf) phenotype, we constructed the following stock: dpy-17
lin-12(n302)/hT2 gfp; cdh-3Tgfp.
The DAPI-staining method and brood size determinations
were as described (Qiao et al. 1995). To generate ego-2 mutant
males, several sets of !30 L4 ego-2(om33) unc-75 hermaphrodites were picked to fresh plates and placed at 30" for !2 hr;
plates were then moved to 20". L4 ego-2(om33) unc-75 males

were picked from the F1 generation and mated with ego2(om33) unc-75/ego-2(tm2272) hermaphrodites at 25" to obtain
ego-2(om33) unc-75/ego-2(tm2272) males. ego-2 males were tested
for a spermatogenesis defect by mating them with fog-1(q253ts)
XX females at a ratio of 1 female:5 males. N2 males were mated
with fog-1(ts) females as a control. ego-2 unc75, ego-2 unc-75;alx-1,
and unc-75 hermaphrodites were mated with N2 males at 25" at
a ratio of 1:3. Parents were transferred daily until no additional
embryos were laid onto the plates. Some matings were also set
up at ratios of 1:1, 1:2, or 1:4 hermaphrodites to males. Within
this range, we noted that the number of males inversely
correlated with brood size of ego-2 unc-75 and ego-2 unc75; alx-1
hermaphrodites. We attribute this effect to the unc-75 marker,
which weakens the hermaphrodites.
Recovery and analysis of deletion allele: The National
Bioresource Project recovered a deletion allele lacking the
first three predicted exons of Y53H1C.2, called tm2272. To
balance tm2272, we crossed unc-75/1 males into individual
hermaphrodite progeny of a tm2272/1 mother, recovered
cross progeny that segregated unc-75, and amplified the DNA
to identify lines carrying the tm2272 deletion. We identified
several tm2272/unc-75 lines, each of which segregated progeny
that died as embryos and young larvae. After the tm2272 was
outcrossed a total of five times and balanced with hIn1, the
lethal phenotype was still associated with the tm2272 chromosome. DNA from individual arrested larvae was amplified by
standard methods; 9/9 animals carried the tm2272 deletion
and did not carry an ego-2(1) allele. We conclude that the
developmental arrest/lethality is caused by or linked to the
tm2272 deletion allele. tm2272 failed to complement om33 for
the Ego and spermatogenesis-defective (Spe) phenotypes.
Dosage studies: ego-2(")/hDf17 animals were generated as
follows. (i) ego-2(om33) unc-75 hermaphrodites were mated
with N2 males, and ego-2(om33) unc-75/11 F1 males were
mated with hDf17/hIn1[unc-54] hermaphrodites. NonUnc
hermaphrodites were picked to single plates and cultured at
25". A subset were Spe; they were stained with DAPI and their
morphology was compared with that of ego-2(om33) unc-75
animals raised at 25". Non-Spe animals included ego-2(om33)
unc-75/hIn1[unc-54] (segregated Unc-75 and Unc-54 progeny), 11/hIn1[unc-54] (segregated Unc-54 progeny), 11/
hDf17 (segregated dead embryos), and self-progeny. (ii) ego2(tm2272)/hIn1[unc-54] hermaphrodites were mated with N2
males; ego-2(tm2272/1) and hIn1/1 F1 males were mated with
hDf17/hIn1[unc-54] hermaphrodites. The surviving progeny of
six matings were scored as Unc or nonUnc. A total of 50
nonUnc hermaphrodites were picked to single plates and
scored for a Spe phenotype; none were Spe. If all crossprogeny genotypes were viable, we expected 1/8 (12.5%) to be
Unc-54. If hDf17/ego-2(tm2272) were inviable, we expected 1/7
(14.2%) of surviving cross progeny to be Unc-54. We observed
16.6% Unc-54 males, suggesting that the hDf17/ego-2(tm2272)
males are inviable (n ¼ 1254 males). (We report the figure for
males because nearly all should be cross progeny.) This result
is consistent with the failure to recover Spe hermaphrodite
cross progeny. The genotypes of the 50 F1 nonUnc hermaphrodites (based on the phenotypes of their progeny) were the
following: 40% hIn1[unc54]/1 (segregated Unc-54); 24%
hDf17/1 (segregated dead embryos); and 36% hIn1[unc54]/
hDf17 or hIn1[unc-54]/ego-2(tm2272) (segregated dead embryos and Unc-54). A subset of the final category segregated
arrested ego-2(tm2272) larvae well as dead embryos.
Single nucleotide polymorphism mapping: We mapped ego2(om33) relative to single nucleotide polymorphisms, using a
strategy similar to that described in Maine et al. (2004). We
made lin-11 ego-2(om33)/HA8;glp-1(bn18ts) and ego-2(om33)
unc-75/HA8; glp-1(bn18ts) strains, where HA8 designates a
chromosome from the polymorphic CB4856 strain. The ego-2,
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unc-75, and glp-1 mutations were generated in a N2 wild-type
background. We recovered lin-11 non-Ego and unc-75 non-Ego
recombinants ½on the basis of the absence of an enhanced glp1(ts) phenotype%, generated homozygous recombinant lines,
and assayed their DNA sequence at a series of polymorphic
sites (Figure 1A). Genomic DNA from each recombinant line
was amplified (at 95" for 1 min; 30 cycles of 94" for 30 sec, 55"
for 30 sec, 70" for 2 min; 70" for 5 min), digested with an
appropriate restriction enzyme, and analyzed by agarose gel
electrophoresis to determine whether it had N2 or CB4856
sequence at the polymorphic site.
RNA interference assays: RNA interference assay (RNAi)
was performed by the feeding method of Timmons et al.
(2001). For this analysis, we used constructs containing a portion of genomic DNA or cDNA for each of the 21 predicted
genes within the 137-kb region. Genomic DNA corresponded
to predicted coding regions. DNA fragments were cloned into
the L4440 vector to generate ‘‘feeding’’ constructs and transformed into Escherichia coli strain HT115 (Timmonset al. 2001).
E. coli strains were grown overnight in liquid culture, seeded
onto NGM-Lite plates (Sun and Lambie 1997) that contained
appropriate concentrations of ampicillin and IPTG, and allowed to grow at room temperature (!20"–22") for !48 hr.
Seeded plates were stored at 15" and used within !2 weeks of
seeding. To ensure consistent expression of the double-stranded
(ds)RNA, the plasmid was routinely retransformed into HT115.
L4 larvae were placed onto the plates at 20"; their progeny
were raised continuously in the presence of the dsRNA.
Three Y53H1C.2 ‘‘feeding’’ constructs were generated. The
partial 39 cDNA, yk1162g8, and two genomic DNA regions (‘‘a’’
and ‘‘b’’ in Figure 1C) were used as inserts. We also performed
ego-2 RNAi in an enhanced RNAi background using rrf-3(0); we
observed defects consistent with ego-2 function in many tissues,
as previously reported by Rual et al. (2004). Two differences
were observed between our data and those of Rual et al.
(2004), probably reflecting the different RNAi protocols used
in the two studies. Rual et al. (2004) reported a blistered
cuticle defect that we did not observe, and they did not report
a coordination defect that we observed.
To test the RNAi sensitivity of alx-1(0) mutants, we generated
a ccIs4251; alx-1(0) strain and a gfp ‘‘feeding’’ construct.
ccIs4251; alx-1(0) and ccIs4251;alx-1(1) were placed on the
gfp feeding strain in parallel, and expression of the GFP-tagged
transgenic protein was evaluated.
cDNA analysis: Sequence analysis indicated that yk1162g08
includes the 39-end of the ego-2 transcript, since it contains a
poly(A) addition sequence (TATAAA) and a terminal poly(A)
sequence. We performed reverse transcriptase DNA amplification reactions to obtain the 59 portion of the cDNA, as
follows. Total RNA was extracted from mixed-stage hermaphrodites using Trizol reagent (Invitrogen, Carlsbad, CA) as described by the manufacturer. First-strand cDNA was prepared
with SuperScript reverse transcriptase (Invitrogen) using an
oligomeric primer corresponding to a sequence in yk1162g08.
Amplification reactions were performed under the following
conditions: 95" for 1 min; 30 cycles of 94" for 30 sec, 55" for 30
sec, 70" for 2 min; and 70" for 5 min. The oligonucleotide
primer used for the reverse transcription reaction corresponded to a sequence in yk1162g08 and is referred to as
‘‘Exon10for’’ (59-TAGGAAGCTTGAGGTGGTGTG-39). Reverse
transcriptase product was amplified with pairs of oligonucleotide primers corresponding to sequences located within
regions ‘‘a’’ and ‘‘b’’ used in the glp-1 enhancement assays
and located within Genefinder-predicted exons (see Figure 1).
Pairs of primers used to perform DNA amplification reactions
were as follows: Exon10for 1 Exon9rev (59-AATACGAGAA
GCGTGTCTCGG-39); Exon10for 1 Exon8rev (59-AACGTCG
AAAGCTCGTCGAAC-39); Exon9for (59-GCTCTTCCATCGC
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ATGAACCG-39) 1 Exon7rev (59-GAAACGCGGAAAAAGAGA
ACG-39); Exon7for (59-CTCATCTCTCCCTGCTGCTCC-39) 1
Exon123rev (59-GGAGGCTCTTCCAATAATGC-39). The prominent amplification product obtained with each primer pair
was cloned into pGEM-T vector (Promega, Madison, WI) and
sequenced. There was extensive overlap between products
from the exon 7–10 region, giving two- to threefold coverage
of most of the sequence; we obtained single-fold coverage of
exons 11–15 and 1–6. A portion of the 59-UTR was obtained
from a cDNA library (a kind gift from B. Barstead). The cDNA
sequence was deposited in GenBank, accession no. EF378622.
We used quantitative RT–PCR to examine ego-2 mRNA levels
in the germline vs. soma. We extracted total RNA by the Trizol
method (above) from 50 wild-type (N2) and glp-4(bn2ts) mutant adults raised at restrictive temperature; the latter have
very few germ cells (Beanan and Strom 1992). RNA was
dissolved into 50 ml DEPC-treated H2O. A total of 1, 2, and 5 ml
of RNA (i.e., from one, two, and five worms, respectively) was
used as template in a 10-ml reverse transcriptase reaction, as
described above. The entire reaction was used as template in
DNA amplification reactions. Reactions were performed using
oligonucleotide primers that flanked an intron, so that any
amplification of genomic DNA (if present as a contaminant in
the RNA preparation) would be detected; the only visible
amplification products corresponded to spliced template.

RESULTS

ego-2 encodes a Bro1-domain protein: Qiao et al.
(1995) mapped ego-2 between dpy-24 and unc-101 on
the right arm of chromosome I. We further mapped ego-2
relative to marker genes and single nucleotide polymorphisms (SNPs) in the region (see materials and
methods). By this strategy, ego-2 was localized to a 137kb interval that was predicted to contain 21 genes (Figure 1B). We next used RNAi to deplete each of the 21
predicted gene products and tested for enhancement of
the glp-1(bn18ts) phenotype in the germline (see materials
and methods). This assay identified one predicted gene,
Y53H1C.2, as an ego gene. Approximately 45% of glp1(bn18ts) animals treated with Y53H1C.1 RNAi developed a Glp-1 sterile defect, where all germ cells prematurely entered meiosis during larval development
and differentiated as sperm (Table 1; Figure 2D). In contrast, glp-1(ts) was not enhanced to sterility by RNAi with
any of the other 20 predicted genes. We concluded that
Y53H1C.2 was an ego gene and tentatively identified it
as ego-2.
At this time, only a partial (39) cDNA, called
yk1162g08, was available for Y53H1C.2 (kindly provided
by Y. Kohara and colleagues, http://nematode.lab.nig.
ac.jp) (see Figure 1). To determine the gene structure,
we first used the glp-1 enhancement assay to delineate
the approximate size of the Y53H1C.2 coding region.
Our original glp-1 enhancement test was carried out with
yk1162g08 as the insert in a ‘‘feeding’’ construct used to
generate dsRNA. We generated two additional feeding
constructs containing upstream genomic DNA as inserts, referred to as ‘‘a’’ and ‘‘b’’ in Figure 1C (see
materials and methods) The glp-1(bn18ts) germline
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Figure 1.—Identification of the ego-2 gene. (A) ego-2 was localized to a 137-kb region by mapping relative to SNPs. Relative
positions of SNPs are shown; the cosmid or yeast artificial chromosome names and chromosomal coordinates of the SNPs are
listed. lin-11 non-ego-2(om33) recombinants were used to determine the left boundary of the ego-2 region, and unc-75 non-ego-2
recombinants were used to determine the right boundary of the ego-2 region. The number of recombinants recovered within each
interval is indicated. (B) Relative locations of the 21 predicted genes in the ego-2 region. (C) Genefinder and ORFeome gene
models for Y53H1C.2 are compared with the cDNA sequence that we obtained. Exons are numbered. The corresponding partial
cDNA, yk1162g08.2, is indicated. Yk1162g08.2 was previously sequenced at the ends (boxes), but not within the central region
(dashed line). We generated dsRNA feeding clones with yk1162g08.2 and genomic DNA corresponding to fragments ‘‘a’’ and ‘‘b’’
as inserts in the plasmid vector (see materials and methods).

phenotype was enhanced by RNAi with each of these
additional constructs, indicating that Y53H1C.2 extended across this !15-kb region.
We next obtained the complete cDNA sequence by using yk1162g08 as a starting point for reverse-transcriptase
DNA amplification (see materials and methods). The
resulting cDNA sequence contains a 4476-nucleotide
open reading frame (Figures 1C and 3A). The predicted
product is a 1492-amino-acid protein with a Bro1 domain
(Figure 3B). The gene structure revealed by our analysis
is different from previously predicted gene models,

although it more closely resembles the Genefinder
prediction (see Figure 1C). Interestingly, the C. briggsae
database contains an annotated gene, CBG04380, whose
predicted product aligns well with EGO-2 throughout
its entirety (BLAST E-value ¼ 0) and is presumably an
ortholog.
Once we determined the Y53H1C.2 cDNA sequence,
we sequenced genomic DNA corresponding to the
exons and exon/intron junctions in the ego-2(om33)
unc75 strain (see materials and methods). We detected a T-to-A substitution at nucleotide 350 in the
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TABLE 1
The loss of ego-2 function enhances glp-1(bn18ts)
in the germline

Genotype
glp-1(bn18ts)
unc-75
ego-2(om33) unc-75
unc-75; glp-1(bn18)
ego-2(om33) unc75;
glp-1(bn18)
ego-2(om33/tm2272)
ego-2(om33/tm2272);
glp-1(bn18)a
ego-2(RNAi)b
ego-2(RNAi);unc-32
glp-1(bn18ts)b,c

Adults/brood
(N)
191
190
192
135
90

6
6
6
6
6

11 (5)
10 (6)
11 (6)
3 (12)
12 (10)

% Glp-1 sterile
(n)
1.4
0
0
0.1
8.5

(957)
(1138)
(1149)
(1620)
(896)

28 6 3 (14)
ND

0 (398)
88 (175)

190 6 8 (12)
134 6 7 (31)

0 (2277)
45 (4160)

Experiments were done at 20". N, number of broods
scored; n, number of animals scored; ND, not determined.
‘‘Glp-1 sterile’’ is the percentage of germlines in which all
germ cells had prematurely exited mitosis, entered meiosis,
and differentiated. Number following the ‘‘6’’ is the standard
error of the mean.
a
Animals were obtained as progeny of ego-2(om33) unc-75/
ego-2(tm2272); glp-1(bn18/1) mothers (whose average brood
size was 36 6 4.5). A total of 321 progeny (nine broods) were
scored; 47/214 ego-2(om33) unc-75/ego-2(tm2272) animals were
Glp-1 sterile, which is 88% (47/53) of the expected number
of glp-1(bn18/bn18) animals. In addition, 8/107 ego-2(om33)
unc-75 animals were Glp-1 sterile, which is 30% (8/27) of
the expected number of glp-1(bn18/bn18) animals.
b
Data are the average of four independent feeding
experiments.
c
A similar degree of enhancement was observed in the absence of the unc-32 marker (data not shown).

protein-coding region that is not present in the parental
unc-32(e189) glp-1(bn18ts) strain (Figure 3, A and B). This
mutation is predicted to cause a valine-to-glutamine
substitution at amino acid 117, a semiconserved residue
within the Bro1 domain (Figure 3, A and B). After we
identified the om33 lesion, S. Mitani and colleagues
recovered a partial deletion within the ego-2/Y53H1C.2
gene region, called tm2272 (National Bioresource Project, http://shigen.lab.nig.ac.jp/c.elegans/index.jsp). The
tm2272 allele lacks 626 nucleotides, beginning 80 nucleotides upstream of the predicted EGO-2 translation
start side; exons 1–3 are deleted (Figure 3A).
EGO-2 structure: The EGO-2 Bro1 region is located
at the amino-terminus of the protein, as is typical for
other Bro1-domain proteins (Figure 3, A and B). A Bro1
domain is present in proteins with a variety of functions,
including mammalian/yeast Alix/Bro1 endocytic proteins, mammalian nonreceptor protein tyrosine phosphatase, type 23 (HD-PTP), and yeast Rim20, a positive
regulator of transcription factor Rim101 activity (Odorizzi
2006). In yeast, the Bro1 region has been shown to be necessary and sufficient for binding a component of endo-
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somal sorting complex required for transport (ESCRT)
III and for localization to endosomal compartments (Kim
et al. 2005).
Many previously described Bro1-domain proteins contain one to two coiled-coil domains downstream of the Bro1
region (see Figure 3C). Coiled-coil domains are protein–
protein interaction motifs that are found in a wide range
of structural and regulatory proteins (Lupas et al.
1991; Mason and Arndt 2004; Rose and Meier 2004).
Using the Paircoil prediction program, we detected two
putative coiled-coil domains downstream of the Bro1 domain in EGO-2 (Figure 3, B and C).
The C-terminal portion of EGO-2 contains extensive
low-complexity sequence and is proline rich. Alix proteins contain several proline-rich protein–protein interaction domains in the C-terminal region (Odorizzi
2006). These specific motifs appear to be absent from
EGO-2, but other proline-rich binding motifs may be
present. It is intriguing that another C. elegans Bro1domain protein, ALX-1, physically interacts with LIN12/Notch in the yeast two-hybrid system and has been
implicated in its trafficking (Shaye and Greenwald
2005).
Loss of ego-2 function enhances a weak glp-1
phenotype in the germline: ego-2(om33) was previously
identified on the basis of its enhancement of the glp1(bn18ts) germline phenotype at 20" (Qiao et al. 1995).
After recombining away other mutations on the original
om33 chromosome, we recharacterized the ego-2(om33)
phenotype. We also characterized the effect of ego2(RNAi) and ego-2(tm2272) on glp-1(ts) (Table 1; Figure
2). When raised at 20", 84% of ego-2(tm2272/om33);glp1(ts) animals (obtained from glp-1(bn18/1) mothers)
had a severe Glp-1 sterile phenotype (Table 1). In these
sterile animals, germ cell proliferation failed in early
larval development and all germ cells prematurely
entered meiosis and differentiated as sperm. Similarly,
we observed a Glp-1 sterile defect in 29% of ego-2(om33);
glp-1(bn18) animals obtained from ego-2(tm2272/om33);
glp-1(bn18/1) mothers (Table 1, legend). Interestingly,
only 8% of adults obtained from an ego-2(om33); glp1(bn18ts) mother were Glp-1 sterile (Table 1), suggesting
that there may be a maternal EGO-2 contribution that
influences the Ego phenotype. Consistent with these
genetic data, 45% of ego-2(RNAi);glp-1(bn18ts) adults (on
average) were Glp-1 sterile (Table 1). ego-2(tm2272) homozygotes did not survive to adulthood, and therefore we
could not characterize enhancement of glp-1(ts) in this
genetic background.
In a glp-1(1) background, germline proliferation was
maintained in ego-2(om33), ego-2(om33/tm2272), and ego2(RNAi) adult germlines (Table 1; Figure 2). Similarly,
germline proliferation was maintained when we performed ego-2 RNAi in the rrf-3(0) genetic background,
where RNAi is enhanced (data not shown). RRF-3 is
a RNA-directed RNA polymerase (RdRP) whose activity limits the RNAi response; sensitivity to RNAi is
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Figure 2.—Enhancement of the glp-1(ts) germline phenotype by loss of ego-2 function. All animals were raised at 20". An asterisk
indicates the distal end of the gonad arm. MZ, mitotic zone; TZ, transition zone (leptotene–zygotene stage); PZ, pachytene zone;
sp, sperm; arrows, oocyte; arrowheads in D, sperm. (A) Development of the glp-1(bn18ts) adult hermaphrodite germline is normal.
Mitotic and meiotic germ cells, developing oocytes, and sperm are present. (B) Mitosis is maintained in ego-2(om33) unc-75 and (C)
ego-2(RNAi) germlines. (D) Glp-1 sterile phenotype caused by ego-2 (Y53H1C.2) RNAi in a glp-1(bn18ts) background. In this animal,
mitotic proliferation ceased early in larval development and germ cells differentiated as sperm. This phenotype resembles that of
ego-2(om33);glp-1(bn18ts) sterile hermaphrodites (see Qiao et al. 1995).

substantially enhanced in many tissues in the rrf-3(0)
mutant, including germline (Simmer et al. 2002). We
conclude that either ego-2 activity is not absolutely
required to maintain germline proliferation or sufficient residual EGO-2 activity remains in our mutants
and dsRNA-treated animals to allow proliferation to
continue.
Loss of ego-2 function enhances a weak lag-2
phenotype in the gonad: We further investigated the
idea that ego-2 positively regulates the GLP-1 signaling
pathway by asking whether ego-2(RNAi) could enhance
the germline sterile phenotype associated with lag2(q420ts) (Lambie and Kimble 1991). In tests at 15",
!10% of lag-2(q420ts) control animals had a Glp-1 sterile
phenotype (n ¼ 577 animals, N ¼ 12 broods). In contrast, 42% of lag-2(q420ts); ego-2(RNAi) animals (on average) had a Glp-1 sterile phenotype (n ¼ 1119 animals,
N ¼ 15 broods). (The percentage of Glp-1 sterility of lag2(q420ts); ego-2(RNAi) animals is the average of two independent RNAi experiments where control and ego-2(RNAi)
animals were grown in parallel.) We conclude that the
loss of ego-2 function enhances the germline-proliferationdefective phenotype of lag-2(ts).
EGO-2 function in the soma promotes germline
proliferation: To investigate whether EGO-2 activity is
required in the germline and/or in the soma, we tested
the ability of ego-2(RNAi) to enhance glp-1(ts) in a genetic
background where RNAi is disabled in the soma. RRF-1
is an RdRP whose function is required for robust RNAi
in the soma; rrf-1(0) mutants have a weak response to
RNAi in the soma, but normal sensitivity in the germline
(Sijen et al. 2001). We compared the effect of ego-2 RNAi
in rrf-1(0);glp-1(bn18ts) vs. rrf-1(1);glp-1(bn18ts) animals
tested in parallel (Table 2). Enhancement of glp-1 was

reduced from !43% Glp-1 sterility in ego-2(RNAi);glp1(bn18ts) animals to !14% Glp-1 sterility in rrf-1(0) ego2(RNAi);glp-1(bn18ts) animals. Therefore, EGO-2 activity
in the soma is critical for germline proliferation. The
weak enhancement observed in the rrf-1(0); glp-1(ts) background may reflect residual RNAi in the soma and/or
indicate that EGO-2 activity in the germline also (weakly)
promotes germline proliferation.
In a complementary approach, we used quantitative
reverse transcriptase DNA amplification to examine ego2 mRNA expression in the germline vs. soma. We compared the ego-2 mRNA expression level in wild type (N2)
vs. glp-4(bn2ts) mutant adults raised at restrictive temperature, which have very few germ cells (Beanan and
Strom 1992). ego-2 mRNA was detected with similar intensity in both strains, indicating that expression is not
germline specific or germline enriched (data not shown).
This result is consistent with our phenotypic data indicating that ego-2 functions in the soma.
Loss of ego-2 function enhances glp-1(ts) in the
embryo: We investigated whether EGO-2 activity positively regulates GLP-1/Notch signaling in other tissues
in addition to the gonad. Several inductive events in the
embryo are mediated by GLP-1 signaling (Priess 2005).
In the early embryo, GLP-1 is maternally provided.
Consequently, non-null glp-1 alleles cause several structural defects in the embryo, resulting in maternal-effect
embryonic lethality (a Mel phenotype) (Austin and
Kimble 1987; Priess et al. 1987). We tested whether ego2(om33) and ego-2(RNAi) could enhance the glp-1(ts) Mel
phenotype. Experimental and control strains were
tested in parallel. At 20", ego-2(om33) enhanced the glp1(bn18ts) Mel phenotype from !15% in glp-1(bn18)
animals to !25% in ego-2(om33); glp-1(bn18) animals
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Figure 3.—ego-2 gene structure. (A) The ego-2 mRNA structure. Boxes indicate exons. The region encoding the Bro1 domain is
shaded; om33 and tm2272 lesions are indicated. UTR, untranslated region. (B) Alignment of amino-terminal domains of EGO-2
(CeEGO2), Mus musculus Alix (MmAlix; accession no. CAA066329), C. elegans ALX-1 (CeALX1; accession no. CAA82667), Homo
sapiens HD-PTP (accession no. NP_056281), and Saccharomyces cerevisiae Bro1 (accession no. P48582). The Bro1 domain is underlined in the alignment. An asterisk indicates the valine residue altered in the om33 allele. (C) The number of coiled-coil domain(s)
in each protein as predicted by Paircoil (probability cutoff: 0.5). The putative coiled-coil domain in ALX-1 reported by Shaye and
Greenwald (2005) was not identified by the Paircoil program.

(Table 3). In separate assays, ego-2(RNAi) enhanced the
glp-1(bn18ts) Mel phenotype from !6% in glp-1(bn18)
animals to !16% in glp-1(bn18); ego-2(RNAi) animals
(Table 3). ½The glp-1(bn18) Mel phenotype is extremely
sensitive to temperature, which is why the baseline
percentage of Mel value varies from one experiment
to another.% To investigate this further, we tested
whether ego-2(om33) could enhance the Mel-specific allele glp-1(e2142ts) (Priess et al. 1987). At 15", glp-1(e2142ts)
mothers produced 0.5% dead embryos; in contrast, ego2(om33); glp-1(e2142ts) mothers produced 14% dead
embryos (Table 3). These results suggest that EGO-2
activity promotes (at least in some instances) GLP-1 signaling in the embryo.

To investigate whether the loss of ego-2 function
specifically enhanced the Glp-1 Mel phenotype, we
assayed for a specific defect associated with loss of
GLP-1 signaling activity. GLP-1 signaling at the four-cell
stage ultimately is required for production of the anterior portion of the pharynx; consequently, the posterior
bulb of the pharynx forms in Glp-1 Mel embryos but the
anterior bulb is absent (Priess et al. 1987). We examined
the dead embryos produced by ego-2(om33) unc-75;glp1(ts);nT1 gfp/1 mothers to evaluate their pharynx
phenotype. The nT1 gfp balancer carries a marker that expresses GFP in the pharynx, allowing us to easily identify
pharyngeal cells. Approximately 50% of ego-2("); glp1(bn18ts) embryos contained a posterior pharynx bulb,

2272

Y. Liu and E. M. Maine
TABLE 2

TABLE 4

Enhancement of glp-1(bn18ts) by ego-2(RNAi) in
rrf-1(0) background

ego-2(RNAi) enhances the loss of lin-12 function in the
AC–VU decision

Genotype
ego-2(RNAi)
rrf-1(0) ego-2 (RNAi)
ego-2(RNAi); unc-32
glp-1(bn18ts)
rrf-1(0) ego-2(RNAi);
unc-32 glp-1(bn18ts)

Brood size (N)

% Glp-1 sterile
progeny (n)

189 6 11 (9)
194 6 5 (8)
128 6 3 (17)

0 (1702)
0 (1546)
43.1 (2189)

140 6 2 (19)

14.4 (2686)

All tests were done at 20". N, number of broods scored; n,
number of animals scored. ‘‘Glp-1 sterile’’ is as described in
the Table 1 legend. Values are the average of three independent sets of RNAi experiments, where each genotype was
tested in parallel. Number following the ‘‘6’’ is the standard
error of the mean.

but no anterior one (data not shown). The remaining
!50% of embryos either died too young to evaluate
pharyngeal development or, in some cases, developed
to the threefold stage and appeared to have both pharyngeal bulbs. We conclude that ego-2(om33) and ego2(RNAi) produce a variable phenotype depending on
the level of residual EGO-2 activity and that the
variability results from defects in one or more different
GLP-1-mediated signaling events, overlaid with defects
in additional, non-GLP-1-mediated events. These data
suggest that EGO-2 function promotes GLP-1/Notch

TABLE 3
ego-2(om33) enhances the glp-1 maternal-effect
embryonic lethality

Temperature
15"
15"
15"
20"
20"
20"
20"
20"
20"
20"

Genotype
glp-1(e2142ts)
ego-2(om33) unc-75
ego-2(om33) unc-75;
glp-1(e2142ts)
glp-1(bn18ts)
unc-75
ego-2(om33) unc-75
unc-75; glp-1(bn18ts)
ego-2(om33) unc75;
glp-1(bn18ts)
unc-36 glp-1(bn18ts)a
ego-2(RNAi); unc-36
glp-1(bn18)a

% dead
Brood size embryos (n)
275 6 10
156 6 18
153 6 14
217
190
192
167
130

6
6
6
6
6

12
10
11
4
15

171 6 9
169 6 7

0.5 (1376)
0.3 (623)
14.2 (1831)
9.8
0.4
0.3
14.8
24.8

(1083)
(1142)
(1152)
(2009)
(1043)

6.3 (1877)
15.9 (1856)

Number following the ‘‘6’’ is the standard error of the
mean. n, number of animals scored.
a
Data are from one RNAi experiment. Additional RNAi experiments were done using a strain with unc-32 as a marker
rather than unc-36. The percentage of embryonic lethality was
3.2% in unc-32 glp-1(bn18) animals (14 broods, 206 6 5 animals/
brood) and 12.6% in ego-2(RNAi); unc-32 glp-1(bn18) (14 broods,
186 6 6 animals/brood).

Genotype
lin-12(1)
lin-12(0)
lin-12(ar170); cdh-3Tgfpb
ego-2(RNAi); lin-12(ar170); cdh-3Tgfpb

% 2 AC

n

0
100
26
50

a
a

195
184

All experiments were done at 20". n, total number of animals scored.
a
Values are from the literature (reviewed by Greenwald
2005).
b
Data are the average of three independent sets of feeding
experiments, where lin-12(ar170) was grown in parallel on
OP50 and the ego-2 RNAi bacterial feeding strain. A Z-test indicates that lin-12(ar170); cdh-3Tgfp is significantly different
from ego-2(RNAi); lin-12(ar170); cdh-3Tgfp (P , 0.05).

signaling in the embryo; however, additional studies must
be done to determine which specific GLP-1/Notch signaling events are affected.
Consistent with our phenotypic results, in situ hybridization data from The Nematode Expression Pattern
Database reveals expression of ego-2/Y53H1C.2 mRNA
in the early embryo (http://nematode.lab.nig.ac.jp). At
present, postembryonic in situ hybridization data are
not available.
Loss of ego-2 function enhances lin-12(lf): We next
examined whether EGO-2 function promotes LIN-12/
Notch signaling activity, focusing specifically on the AC–
VU decision. During wild-type development, two cells in
the larval gonad, Z1.ppp and Z4.aaa, interact via LIN-12mediated lateral signaling; one cell eventually forms an
AC and the other cell forms a VU precursor (Greenwald
2005). LIN-12 activity is required for the VU fate
(Greenwald et al. 1983). We tested whether ego-2 activity promotes LIN-12/Notch signaling by testing for
enhancement of a weak lin-12 mutation, lin-12(ar170),
in the AC–VU decision. We scored the number of ACs
present in L3 stage larvae and used CDH-3TGFP as an
AC marker (see materials and methods). CDH-3 is a
cadherin that is expressed in a number of epithelial
cells; it is expressed at a high level in the newly formed
AC (Pettitt et al. 1996; Inoue et al. 2002). At 20", we observed two ACs (indicating a failure in LIN-12-mediated
signaling) in 26% of lin-12(ar170) larvae, similar to reported values (Hubbard et al. 1996; see also Chen et al.
2004) (Table 4). We consistently observed enhancement
of the two-AC defect to 50% in ego-2(RNAi); lin-12(ar170)
larvae (Table 4). We conclude that EGO-2 activity promotes LIN-12/Notch signaling in the Z1.ppp-Z4.aaa
interaction.
We also tested whether ego-2(RNAi) altered the AC–
VU decision in a lin-12(1) background using a lin12(1);cdh-3Tgfp strain. All animals observed had only a
single AC, suggesting that the effect of ego-2(RNAi) on
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LIN-12 signaling activity is too mild to produce an effect
in this nonsensitized background (data not shown).
Can ego-2(lf) suppress hyperactive GLP-1 or LIN-12
activity? To further investigate how EGO-2 activity
promotes Notch signaling, we tested whether glp-1(gf)
or lin-12(gf) defects could be suppressed by the loss of
ego-2 function. glp-1(oz112gf) causes unregulated germline proliferation, resulting in a tumorous germline
(Berry et al. 1997). Neither ego-2(om33) nor ego-2(RNAi)
suppressed the glp-1(oz112) tumor (data not shown).
However, a subtle decrease in tumor size might not be
easily observed. Consequently, we tested for suppression
of a weaker hypermorphic allele, glp-1(ar202), and suppression of the semidominant lin-12 allele, lin-12(n302)
(Greenwald et al. 1983). To test for suppression of lin12(n302), we constructed a dpy-17 lin-12(n302)/hT2 gfp;
cdh-3Tgfp strain and assayed for the presence of an AC in
lin-12(n302/1); ego-2(RNAi) animals as described above
for the lin-12(ar170) experiment (see materials and
methods). A total of 67% of lin-12(n302/1) control
animals (n ¼ 21) and 64.5% of ego-2(RNAi); lin-12(n302/1)
animals (n ¼ 31) failed to form an AC. To test for
suppression of glp-1(ar202), we assayed the proximal proliferation phenotype in L4/young adult hermaphrodites
(L1 1 48 hr) raised at 25". Proximal proliferation was
visible in 32% (n ¼ 62) of glp-1(ar202) controls and 20%
(n ¼ 60) of ego-2(RNAi); glp-1(ar202) animals. Taken
together, these data suggest that the loss of ego-2 function does not suppress a weak glp-1 or lin-12 hypermorph.
The relationship between EGO-2 and the meiotic
entry pathways: Downstream of GLP-1 signaling, the
GLD-1 and GLD-2 pathways act redundantly to promote
germ cell entry into meiosis and/or to inhibit continued
germ cell proliferation (Hansen and Schedl 2006).
Meiotic entry is severely impaired in gld-2(0) gld-1(0)
double mutants, and germ cells overproliferate to form
a tumor (Kadyk and Kimble 1998; Hansen et al. 2004).
The few germ cells that do enter meiosis never proceed
beyond the leptotene–zygotene stage (Hansen et al.
2004). We examined the gld-2(0) gld-1(0) ego-2(om33) and
gld-2(0) gld-1(0) ego-2(RNAi) germlines to determine
whether a reduction in ego-2 activity could suppress the
gld-2 gld-1 meiotic entry defect. In both cases, the proportion of leptotene–zygotene germ cells was approximately the same as in the gld-2 gld-1 control, and pachytene
germ cells were not observed (data not shown).
EGO-2 function promotes spermatogenesis: We
noted that ego-2(om33) animals raised at 25" produced
very few progeny (33 6 5) (Table 5), as did ego-2(tm2272/
om33) animals at 20" (28 6 3) (Table 1). In addition,
these animals prematurely laid unfertilized oocytes
intermittently with fertilized eggs. We monitored these
animals and visually inspected them after they had
stopped producing embryos. At this point, they retained
sperm in the spermatheca (data not shown). Typically,
wild-type hermaphrodites do not lay unfertilized oocytes until they are depleted of sperm, and each wild-
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TABLE 5

ego-2 and alx-1 promote spermatogenesis

Genotype
Wild-type (N2) hermaphrodite
ego-2(om33) unc-75 hermaphrodite
ego-2(om33) unc-75
hermaphrodite 3 1/1 malea
ego-2(om33) unc-75
hermaphrodite 3 1/1 maleb
unc-75 hermaphrodite
3 1/1 maleb
unc-75; alx-1(0) hermaphrodite
ego-2(om33) unc-75; alx-1(0)
hermaphrodite
ego-2(om33) unc-75; alx-1(0)
hermaphrodite 3 1/1 maleb
ego-2(tm2272/om33)
male 3 fog-1(ts) femalec,d
1 male 3 fog-1(ts) femalec

Temperature

Brood
size

N

25"
25"
25"

155 6 10 10
33 6 5 10
170 6 7 12

25"

119 6 5

25"

177 6 14 7

25"
25"

124 6 8 11
6 6 1 10

25"

117 6 6 10

25"

,1 6 1 25

25"

71 6 4 10

5

N, total number of broods scored. Number following the
‘‘6’’ is the standard error of the mean. Broods were assayed
on consecutive days, until at least 1 day after hermaphrodites
had stopped producing embryos. At this point, visual examination revealed the presence of (apparently nonfunctional)
sperm in ego-2(om33) unc-75 and ego-2 unc75; alx-1 hermaphrodites and in the mating partners of ego-2(tm2272/om33) males.
a
Two males mated with each hermaphrodite.
b
Three males mated with each hermaphrodite.
c
Five males mated with each hermaphrodite. unc-75-marked
hermaphrodites consistently fared better when mated with
fewer males.
d
Only four matings produced progeny (one to five per
mother).

type sperm will typically fertilize an oocyte. Hence, it
appeared that ego-2(") mutants had a Spe defect.
Consistent with this, we also noted that the ego-2(")
hermaphrodites accumulate endomitotic oocytes in the
uterus.
To confirm that the small brood sizes result from a
defect in sperm rather than an oocyte function, we
asked if the ego-2 hermaphrodite brood size could be
increased by mating with wild-type (N2) males (see
materials and methods). Upon mating at 25", brood
sizes of ego-2(om33) unc-75 hermaphrodites increased
substantially, indicating that the oocytes were functional
and could be fertilized by wild-type sperm (Table 5). We
conclude that the ego-2(om33) hermaphrodites (at 25")
have an incompletely penetrant sperm defect.
To investigate whether ego-2 promotes spermatogenesis in males, we generated ego-2(tm2272/om33) males
and mated them with fog-1(q352ts) females raised at 25"
(see materials and methods). When wild-type (N2)
males were mated with fog-1(ts) females at 25", 10/10
matings produced progeny (Table 5). In contrast, when
ego-1(tm2272/om33) males were mated with fog-1(ts)
females, only 4/25 matings produced progeny, and
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the number of progeny was extremely small (Table 5).
Visual inspection indicated that ego-2(tm2272/om33)
males produced substantial numbers of sperm, and
the mated fog-2(ts) females contained sperm, indicating
that sperm had been transferred (data not shown). On
the basis of these data, we conclude that ego-2(tm2272/
om33) males produce defective sperm.
Additional ego-2 functions: A variety of defects were
observed in the somatic tissues of ego-2(tm2272) and ego2(RNAi); rrf-3(0) animals, at least some of which are in
processes not known to involve Notch signaling. The ego2(tm2272) allele is associated with developmental
arrest/lethality of embryos/young larvae. We did not
observe significant levels of embryonic or early larval
lethality when ego-2 RNAi was performed in the ego2(om33) mutant background or in the rrf-3(0) enhanced
RNAi background. However, ego-2(RNAi) animals developed slowly, reaching adulthood !24 hr later than
controls; they were also uncoordinated (data not shown).
ego-2(RNAi) adults had an egg-laying (Egl) defect, perhaps reflecting a vulval defect. Taken together, these
phenotypic data indicate that EGO-2 activity is important for multiple aspects of development.
We were concerned that ego-2(RNAi) did not phenocopy the lethality that is associated with tm2272 and
considered that the lethality might arise from a second
linked mutation alone or in combination with tm2272.
To examine this issue, we evaluated the phenotypes of
ego-2(tm2272)/hDf17 and ego-2(om33)/hDf17 animals (see
materials and methods). hDf17 uncovers the ego-2 gene
region (see http://www.wormbase.org). ego-2(om33)/hDf17
hermaphrodites are Spe and resemble ego-2(om33/tm2272)
animals (data not shown). This result suggests that
tm2272 behaves like hDf17 and is null for ego-2 function.
In contrast, we were not able to recover ego-2(tm2272)/
hDf17 adults, suggesting that this genotype is lethal (see
materials and methods). Alternatively, hDf17 might
uncover a second linked mutation that causes the lethality. To try to resolve this question, we generated an
ego-2(1) construct and used it to generate multicopy extrachromosomal transgenic arrays. Two different transgenic arrays, omEx35 and omEx36, were crossed into the
ego-2(tm2272/1) background, and ego-2(tm2272);omEx35
and ego-2(tm2272);omEx36 adult hermaphrodites were recovered (Y. Liu and E. Maine, unpublished data). Therefore, the ego-2(1) transgenic arrays apparently rescued
the early larval lethality, indicating that the lethality is
associated with the tm2272 deletion. A formal possibility
remains, however, that this is a synthetic lethality caused
by tm2272 and a second linked mutation (uncovered by
hDf17).
ego-2 and alx-1 interact genetically: Shaye and
Greenwald (2005) have previously shown that ALX-1
physically interacts with LIN-12/Notch in the yeast twohybrid system and acts as a negative regulator of LIN-12
activity. During vulva formation, LIN-12 is downregulated in the vulval precursor cell (VPC) that takes on the

TABLE 6
alx-1(0) suppresses the enhancement of glp-1(ts) by ego-2
in the germline
Genotype
ego-2(RNAi)
alx-1(0)
unc-36 glp-1(bn18)
unc-36 glp-1(bn18)
alx-1(0)
ego-2(RNAi); alx-1(0)
ego-2(RNAi); unc-36
glp-1(bn18)a
ego-2(RNAi); unc-36
glp-1(bn18) alx-1(0)a

Brood size (N)
192
234
171
178

6
6
6
6

6
6
9
7

% Glp-1 sterile (n)

(3)
(19)
(11)
(10)

0 (575)
0.1 (4453)
1.0 (1877)
0.1 (1783)

186 6 3 (6)
168 6 7 (11)

0 (1114)
27 (1856)

177 6 8 (8)

11 (1413)

All tests were done at 20". ‘‘Glp-1 sterile’’ is as described in
the Table 1 legend. N, number of broods scored; n, number of
animals scored.
a
Two independent RNAi experiments were done. We consistently observed reduced enhancement of glp-1 in alx-1(0) vs.
alx-1(1) animals.

primary fate, typically P6.p; ALX-1 activity is required for
LIN-12 degradation after internalization in the 1" VPC
(Shaye and Greenwald 2005). On the basis of their
analysis of ALX-1 localization and its molecular structure, Shaye and Greenwald (2005) propose that ALX-1
associates with the multivesicular endosome. We investigated whether ALX-1 activity promotes GLP-1/Notch
signaling and the functional relationship between ALX-1
and EGO-2.
To examine these questions, we first constructed a glp1(bn18ts) alx-1(0) double mutant and tested for enhancement of glp-1(ts) in the germline at 20". We did
not observe enhancement (Table 6). Next, we tested
whether alx-1 might potentiate the enhancement of glp1 by ego-2. Surprisingly, the Glp-1 phenotype was less
pronounced in ego-2(RNAi);glp-1(bn18ts) alx-1(0) germlines compared with the ego-2(RNAi); glp-1(bn18ts) germlines (Table 6). This result suggested that EGO-2 and
ALX-1 may have opposite functions with respect to GLP1 pathway activity, at least in the germline. Alternatively,
alx-1(0) mutants may have reduced sensitivity to RNAi.
To test this possibility, we constructed an alx-1(0) strain
that carried a gfp-tagged transgene (ccIs4251) and performed RNAi, targeting the gfp mRNA for degradation
(see materials and methods). GFP expression was reduced to below visible levels in both alx-1(1) and alx-1(0)
strains upon gfp RNAi (data not shown). Hence, alx-1(0)
mutants are sensitive to RNAi.
We also examined the phenotype of ego-2(lf);alx-1(0)
animals in a glp-1(1) background. At 25", the ego2(om33); alx-1(0) double mutant had a brood size of
6 6 1, which is substantially smaller than the ego-2(om33)
single mutant (Table 5). Visual inspection indicated that
these animals retained a population of mitotic germ cells
and were actively making oocytes; they also retained
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significant stores of sperm, which apparently could not
fertilize the oocytes. Consistent with this conclusion,
endomitotic oocytes were present in the uterus (but not
in the oviduct). To confirm that the sperm were defective, we mated ego-2(om33) unc-75; alx-1(0) hermaphrodites with wild-type (N2) males at 25" and assayed their
brood sizes (see materials and methods). The average
brood size increased substantially (Table 5), indicating
that the ego-2(om33);alx-1(0) oocytes can be fertilized by
wild-type sperm. We conclude that most ego-2(om33);alx1(0) self-sperm were defective. As we observed for unmated ego-2;alx-1 double mutants, visual examination of
mated ego-2(om33);alx-1(0) hermaphrodites revealed that
their germline retained a distal mitotic population and
were actively producing oocytes. We conclude that alx1(0) interacts synergistically with ego-2(om33) to cause a
more highly penetrant spermatogenesis defect than is
produced by ego-2(om33) alone.
DISCUSSION

ego-2 was previously identified as a positive regulator
of germline proliferation that interacts genetically with
glp-1 (Qiao et al. 1995). Here, we have characterized the
ego-2 gene structure and shown that its conceptual
translation product is a Bro1-domain protein. We
demonstrated that the loss of EGO-2 function impairs
signaling via GLP-1/Notch in the germline and embryo
and via LIN-12/Notch in the AC–VU decision. We also
demonstrate that the loss of EGO-2 function impairs
signaling via LAG-2, the predominant DSL-type ligand
known to act in the DTC and in the AC–VU precursors.
In the embryo, EGO-2 activity presumably promotes
activity via additional ligands, e.g., APX-1. Additional
experiments will be required to determine whether
EGO-2 is a universal promoter of Notch-type signaling
in all tissues.
Our data indicate that EGO-2 activity in the soma
positively regulates germline proliferation in the sensitized glp-1(ts) background. We hypothesize that it is
specifically EGO-2 expression in the somatic gonad that
promotes GLP-1 signaling in the germline, although
additional expression data will be required to confirm
this hypothesis. In addition, our data also suggest that
EGO-2 activity in the germline itself positively regulates
proliferation.
The relationship between EGO-2 and ALX-1: Our
genetic data suggest a complex functional relationship
between EGO-2 and the related Bro1-domain protein,
ALX-1. The two proteins appear to act in opposition
with respect to some processes (e.g., GLP-1/Notch signaling in the gonad) and in concert with respect to other
ones (e.g., spermatogenesis). ALX-1 activity has been
shown to promote downregulation of internalized LIN12TGFP in the 1" VPC during vulval development, and
GFPTALX-1 was shown to localize to subcellular foci
that are suggestive of endosomal compartments (Shaye
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and Greenwald 2005). More recently, GFPTALX-1 was
shown to colocalize with integral endosomal components
(B. Grant, personal communication), strengthening the
hypothesis that ALX-1 regulates LIN-12 trafficking. Although alx-1(RNAi) did not mimic a lin-12 mutant phenotype in the vulval precursor cell interaction (Shaye
and Greenwald 2005), it remains to be shown whether
alx-1(0) can enhance or suppress the lin-12(") phenotype in certain tissues. Given the observations of Shaye
and Greenwald (2005) and the data reported here, we
hypothesize that ALX-1 may be a negative regulator of
GLP-1 activity in the germline.
EGO-2 functions in events not known to require
Notch activity: EGO-2 activity also promotes aspects of
somatic and germline development that have not yet
been linked to Notch signaling. We speculate that EGO2 functions in the trafficking or regulation of additional
cell-surface proteins whose activities promote these
other aspects of development. In spermatogenesis, for
example, EGO-2 may function in endocytic events that
regulate a number of different events, e.g., biogenesis
of the membraneous organelle or its function during
spermiogenesis or trafficking/activation of cell-surface
proteins that mediate sperm–egg binding (reviewed by
L’Hernault 2006).
EGO-2 may function in endocytic processes that
promote Notch signaling: Bro1-domain proteins have
been implicated in a variety of cellular processes in
fungi, plants, and animals. Several Bro1-domain proteins, as well as the isolated Bro1 domain itself, have
been shown to localize to late endosomes and contain a
binding motif for a specific subunit of ESCRT-III (Kim
et al. 2005). ESCRT-I, -II, and -III are protein complexes
that function in trafficking (mono-ubiquitinated) transmembrane proteins to multivesicular bodies. Although
we have not demonstrated here that EGO-2 localizes to
endosomes, this hypothesis is strengthened by the observation that ALX-1 does so (B. Grant, personal
communication).
Classically, endocytosis has been understood to function in the negative regulation of signal transduction,
e.g., by removal of spent receptor from the plasma membrane. More recently, endocytosis has been shown to
promote signal transduction in many situations, although
the mechanisms by which this occurs are not clear
(Maxfield and Mcgraw 2004; Miaczynska et al. 2004).
Studies in several organisms have shown that Notch-type
signaling is subject to both positive and negative regulation via endocytosis (Le Borgne et al. 2005; Wilkin
and Baron 2005; Chitnis 2006). In C. elegans, endocytic
processes have been implicated in the positive regulation of Notch signaling in the gonad, where inactivation
of epsin in the somatic gonad has been shown to
enhance the phenotype of a weak glp-1 loss-of-function
mutation in the germline (Tian et al. 2004).
Various models have been proposed for how endocytosis might promote Notch-type signaling (see Miaczynska
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et al. 2004; Le Borgne et al. 2005; Chitnis 2006; Le
Borgne 2006; Nichols et al. 2007). It has been posited
that, in the signaling cell, endosomal trafficking may be
required for activation or secretion of ligand and that
endocytosis of ligand following its interaction with Notch
is required for subsequent cleavage of Notch. In the receiving cell, activation of signaling components similarly
may be mediated via endocytosis, and/or the final (S3)
cleavage event may occur within endocytic vesicles (GuptaRossi et al. 2004). Since EGO-2 has a Bro1 domain and
Bro1-domain proteins have been implicated in endosomal
trafficking, we speculate that EGO-2 functions in one or
more such endosomal process(es) to promote Notch-type
signaling in C. elegans. Investigation of the EGO-2 localization pattern and the effect of ego-2 mutations on endosomal trafficking will help to resolve these issues. Moreover,
it will be of interest to investigate whether Bro1-domain
proteins regulate Notch-type signaling in other species.
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